Authors


Matthew Seamon, PharmD, Esq

Latest:

Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of Care

After discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.


Ambree Gober, PharmD candidate

Latest:

Protein S Deficiency

Protein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.


Christine Muglia, MD

Latest:

Alpha-Gal (Mammalian Meat) Allergy: Implications for Pharmacists

Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.



John M. Mulvaney, MHA

Latest:

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)

The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.



Michael Page, PharmD RPh

Latest:

Head Lice Treatment: Perspective for Pharmacists

An estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.


Sneha Baxi Srivastava, PharmD

Latest:

Heart Failure: Implications for Quality Improvement and Hands-on Training

This Continuing Education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..


Jasmina I. Ivanova, MA

Latest:

Do Units and Costs of Comparable Insulins Differ by Manufacturer?

Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.




Hyma Gogineni, PharmD, MSc, BCACP, APH, TTS

Latest:

Summary of Current SARS-CoV-2 Vaccine Trials

Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.


Becky Rand, VP Manufacturer Relations, ExceleraRx Corp

Latest:

Improving the Patient Journey Through Health System Partnerships Enhances Care

Health system specialty pharmacies are creating a more integrated care structure for complex patients on specialty drug regimens.


Kangho Suh, PharmD Candidate

Latest:

Diabetes Quality Measurement: A Primer for Pharmacists

The continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.


James Jorgenson, MS, RPh, FASHP

Latest:

Is PBM Transparency an Answer to Controlling Rising Drug Costs?

With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.


Christopher Ciano, RPh

Latest:

Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program

Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.


Erin P. Saito, PhD

Latest:

Copayment Level and Drug Switching: Findings for Type 2 Diabetes

Among insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.


Jennifer Neal, PharmD

Latest:

Chemotherapy and Obesity

When giving antineoplastics to obese and morbidly obese patients, clinicians must be careful not to under- or overdose.


Leonor Rojas, PharmD, BCPS, BCIDP

Latest:

What Are the Implications of the MERINO Trial?

Is piperacillin/tazobactam an effective carbapenem alternative to treat bloodstream infections caused by ESBL-producing enterobacteriaceae.


Thomas J. Bramley, PhD

Latest:

Review of Outcomes Associated With Formulary Restrictions: Focus on Step Therapy

As healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.



Kristin Chambers

Latest:

Patient-Centered Care: The Case for Site Expansion to Include Health System Specialty Pharmacy

Health systems and manufacturers need to work together to obtain inclusion for health system specialty pharmacies so that patients can fill their prescriptions within a coordinated care ecosystem.


Alina Cernasev, PharmD

Latest:

Pharmacy Technicians Contribute to Positive Outcomes for Patients Using Opioids by Avoiding Stigma

Perhaps no other health care worker has been exposed to the opioid epidemic more frequently than pharmacy technicians and pharmacists.


Mitchell Shiffman, MD

Latest:

Hepatitis C Management: How Payers, Providers, and Pharmacies Can Work Together to Stem Costs

New models of collaboration can guide providers in optimizing care for patients with HCV.


Rosanne C. Harrigan, MS, EdD

Latest:

Copayment Level and Drug Switching: Findings for Type 2 Diabetes

Among insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.



A. Lee Bentley, III

Latest:

Justice Department Places Increased Scrutiny On Pharmacies, Pharmacists

Federal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.


Brian P. Murray, MD

Latest:

Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder Interventions

This cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.


Justin Powell, PharmD Candidate

Latest:

Prostate Cancer: Facts, Causes, and Treatments

Prostate cancer is the leading cancer in men, with about 1 in 8 developing it in his lifetime.


Rachael Ortiz, MBA, CPhT, FCSHP

Latest:

Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.